Seattle Children's Hospital

Crippling Life Support for SARS-CoV-2 Through Synthetic Lethality

Research Alert

Significance of paper
Newswise — This paper authored by a group of scientists from the Center for Global Infectious Disease Research at Seattle Children's Research Institute presents a promising concept for disrupting the life cycle of a virus using synthetic lethality. When viruses infect cells they alter the state of their host cell making these host cells vulnerable to treatments to which they would otherwise be insensitive. We are suggesting that you can identify and target these vulnerabilities in virally-infected host cells. If you can kill the host cell, you can kill the “factory” that is responsible for replicating the virus, thereby disabling the virus while leaving the healthy cells alone.

Synthetic lethality has been successful in cancer therapies where drugs are designed to attack specific alterations in the cancer cell. However, the strategy is largely unused to combat viral infections. The authors on this paper come from a variety of backgrounds – immunology, cell biology, systems and synthetic biology, proteomics, and virology – and that has allowed us to think about this concept in a new way with respect to viral diseases.

The targets revealed using synthetic lethality can be compared to an airplane at the gate versus one that is midflight. The vulnerabilities for an airplane sitting on the ground are very different from when it is in the air. The same is true for a host cell – there are very different vulnerabilities when it is working normally versus when it is under attack by a virus. We believe we can disrupt the viral life cycle by exploiting those vulnerabilities.

Future directions and next steps
First, we are working to demonstrate that the synthetic lethality concept is viable in viral diseases – that selectively disrupt the virally-infected host cell and eradicate the virus by specifically targeting the identified vulnerabilities. Once we establish proof of concept, we can then apply synthetic lethality to develop targeted and selective therapeutics to address viruses like SARS-CoV-2.

With synthetic lethality, we expect to uncover many more alterations we can potentially target with drugs than when we only look at the virus itself. Readily available computational tools can then help us mine for drugs capable of targeting the alteration and inhibiting the host cells from producing virus. We believe existing data sets, reexamined using synthetic lethality, may very likely hold answers that can help develop more effective therapies against SARS-CoV-2 or other deadly viruses. We may also find therapies that slow infection, offering possible preventive measures.  

Looking at the bigger picture, we hope our efforts will expose common host functions used by many viruses. By working now to develop synthetic lethal drug approaches based on these shared targets, we can more quickly and comprehensively counter future global outbreaks.

Crippling Life Support for SARS-CoV-2 and other Viruses Through Synthetic Lethality
Fred D. Mast, Arti T. Navare, Almer M. van der Sloot, Jasmin Coulombe-Huntington, Michael P. Rout, Nitin S. Baliga, Alexis Kaushansky, Brian T. Chait, Alan Aderem, Charles M. Rice, Andrej Sali, Mike Tyers, and John D. Aitchison

Published in the Journal of Cell Biology, August 2020


Filters close

Showing results

110 of 3385
Released: 24-Sep-2020 11:15 AM EDT
Preparing for asthma attacks during a pandemic
University of Texas Health Science Center at Houston

Cooler weather, pumpkins, and falling leaves – all things that kick off the most wonderful time of year, the holiday season. But for asthma sufferers, this could mean trouble because experts see an increase in asthma attacks toward the end of September.

Newswise: Double-lung transplant for COVID-19 patient performed by team of UTHealth physicians
Released: 24-Sep-2020 11:10 AM EDT
Double-lung transplant for COVID-19 patient performed by team of UTHealth physicians
University of Texas Health Science Center at Houston

Just 12 hours after undergoing a double-lung transplant, 70-year-old Francisco Medellin was sitting up in a chair pushing bike pedals – a seemingly simple act that was the culmination of hard work by a dedicated multidisciplinary team from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).

Newswise: Antibodies protect against wide range of influenza B virus strains
22-Sep-2020 11:50 AM EDT
Antibodies protect against wide range of influenza B virus strains
Washington University in St. Louis

Researchers have identified two antibodies that protect mice against lethal infections of influenza B virus, report scientists at Washington University School of Medicine in St. Louis and Icahn School of Medicine at Mount Sinai. Together with an antibody that targets the other major kind of influenza viruses that infect people — influenza A — these antibodies potentially could form the basis of a broad-spectrum flu drug that could treat almost all flu cases.

Released: 24-Sep-2020 10:45 AM EDT
Uncovering a ‘suPAR’ culprit behind kidney injury in COVID-19
Michigan Medicine - University of Michigan

A new observational study finds patients in the hospital for COVID-19 have high levels of soluble urokinase receptor (suPAR), an immune-derived pathogenic protein that is strongly predictive of kidney injury.

Released: 24-Sep-2020 10:35 AM EDT
Climate pledges 'like tackling COVID-19 without social distancing'
University of Exeter

Current global pledges to tackle climate change are the equivalent of declaring a pandemic without a plan for social distancing, researchers say.

Released: 24-Sep-2020 10:10 AM EDT
Rebound or Permanent Slump? Possible Impacts of US COVID-19 Fiscal Policies
University of Virginia Darden School of Business

Fiscal policy is a powerful tool to combat economic downturns, but the results depend on decreasing inequality, an imperative to the efficacy of fiscal multipliers. As COVID-19 cases rise, new research offers insights into which fiscal policies may bolster the economy — and the other options, which may have long-term ramifications.

access_time Embargo lifts in 2 days
Embargo will expire: 24-Sep-2020 2:00 PM EDT Released to reporters: 24-Sep-2020 9:25 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Sep-2020 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 24-Sep-2020 5:05 AM EDT
Many Americans continue to maintain unhealthy lifestyle habits during COVID-19; overeating, alcohol drinking and marijuana use increase while exercise declines, reports USC Center for the Digital Future
USC Annenberg School for Communication and Journalism

After more than six months of living in a pandemic, large percentages of Americans continue to indulge in unhealthy lifestyle habits, including overeating and increased use of alcohol and marijuana — all while many are exercising less, according to a study of the cultural impact of COVID-19 conducted by the USC Center for the Digital Future (CDF).

Newswise: Houston Methodist COVID-19 study shows rapid spread and potential for mutant viruses
Released: 23-Sep-2020 4:55 PM EDT
Houston Methodist COVID-19 study shows rapid spread and potential for mutant viruses
Houston Methodist

Molecular analysis of COVID-19’s powerful second wave in Houston shows a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085 COVID-positive patients tested at Houston Methodist since early March show a virus capable of adapting, surviving and thriving – making it more important than ever for physician scientists to understand its evolution as they work to discover effective vaccines and therapies.

Newswise: Likely molecular mechanisms of SARS-CoV-2 pathogenesis are revealed by network biology
Released: 23-Sep-2020 4:00 PM EDT
Likely molecular mechanisms of SARS-CoV-2 pathogenesis are revealed by network biology
University of Alabama at Birmingham

Researchers combined a lung-epithelial cell host interactome with a SARS-CoV-2 interactome. Network biology analysis of this human/SARS-CoV-2 interactome revealed potential molecular mechanisms of pathogenesis for SARS-CoV-2, the virus responsible for the COVID-19 pandemic.

Showing results

110 of 3385